Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
10901 Kenwood Road, Blue Ash, OH, 45242, US
Resilience is a North American CDMO focused on delivering high-quality, scalable manufacturing solutions for advanced therapies. With capabilities spanning biologics drug substance, cell-based therapies, and aseptic drug product manufacturing for both small and large molecules, Resilience partners with biopharma companies to bring complex medicines to market faster and more reliably. The company is building a streamlined, high-performance network designed to meet the evolving needs of clinical and commercial-stage innovators. For more information, visit https://resilience.com/ and follow us on social media: Resilience on LinkedIn.
Strengthens its ability to provide a seamless path from DNA to IND submission for its customers.
By: Charlie Sternberg
The partners seek to define and subsequently develop an allogeneic pancreatic beta cell therapy based on patient needs.
By: Patrick Lavery
Alliances and expertise behind advancing CGTs in today’s market.
By: Kristin Brooks
Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.
By: Roger Herr, Patrick Kellish
Advantages of integrated, QbD-guided formulation development services and key strategies for minimizing risk and maximizing success.
By: Eliza Yeung, PhD
Once operational, the facility will be the company's key drug product facility designed to meet the latest and most stringent requirements for international markets.
DNA‑to‑IND offering leveraging GS Ori‑Go designed to deliver tox material in approximately two months, and IND readiness in as little as six months.
Collaboration targets lower-dose therapies for genetic muscle disease and in vivo cell therapy.
Margin compression, tariff exposure, and supplier consolidation are piling pressure on contract manufacturers. But single-use technology redrew the competitive landscape and a second wave in cell and gene therapy is doing it again.
By: Dan Stanton
The facility becomes the 18th in WuXi Biologics’ global network.
Biotech companies partner to develop low-dose, targeted AAV gene therapies for cardiac disease.
Will provide microbial contract development and manufacturing services for the recombinant human matrix metalloproteinase-7.
Catalent to support gene therapy manufacturing for SPG50 and other pipeline programs.
Addresses manufacturing challenges related to scalability, cost of goods and process consistency as gene therapy programs move toward commercialization.
The therapy is intended for patients with refractory leukemia or other hematologic malignancies who have exhausted the standard options.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
